Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol for Anemia in Severe CKD/PD
NCT01942460Phase 4Completed
- Start
- Sep 2013
- Primary completion
- May 2014
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferumoxytol in iron deficiency anemia (IDA). Primary endpoint: Change in hemoglobin, serum ferritin and transferrin saturation at 4 weeks. Started Sep 2013; status: completed.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01942460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01942460.